If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGcp Asset Bckd Regulatory News (GABI)

Share Price Information for Gcp Asset Bckd (GABI)

Share Price is delayed by 15 minutes
Get Live Data
65.40    0.00 (0.00%)
Bid:
64.00
Ask:
66.40
Spread: 2.40 (3.75%)
Market Cap: £112.42m
GABI Live PriceLast checked at - London Stock Exchange

Intraday Gcp Asset Bckd Share Chart

Quarterly Update

26 Jul 2024 07:00

RNS Number : 8461X
GCP Asset Backed Income Fund Ltd
26 July 2024
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION

 

FOR IMMEDIATE RELEASE

26 July 2024

GCP Asset Backed Income Fund Limited

("GABI" or the "Company")

LEI: 213800FBBZCQMP73A815

Quarterly Update

GCP Asset Backed, which invested in asset backed loans, announces that, at 30 June 2024, the unaudited net asset value ("NAV") per ordinary share of the Company (including current period revenue) is 90.92 pence per share.

NAV

The NAV represents a quarterly decrease of 0.33 pence per ordinary share (0.36%) from 31 March 2024. This decrease primarily reflects asset-specific revaluations, including loan-specific impairments and discount rate movements. The weighted average discount rate of the portfolio at 30 June 2024 was 10.37%, a decrease of 0.32 percentage points over the quarter (largely resulting from the evolution of the underlying portfolio as a result of the repayments received) and an increase of 1.07 percentage points since 30 June 2023.

Capital allocation

During the quarter ending 30 June 2024, the Company did not make any investments. As of 30 June 2024, the revolving credit facility ("RCF") commitments were reduced to £1 million to lower ongoing financing costs, primarily commitment fees, ahead of the RCF's maturity in August 2024. The reduced facility has been retained for use in relation to the Company's FX hedging contracts. Cash on hand as of 30 June 2024 was £5.6 million.

The initial capital distribution, as declared on 3 June 2024 was made on 24 June 2024. On a pro rata basis, 159,609,669 ordinary shares, representing approximately 37.5% of the Company's issued shares, were compulsorily redeemed at 89.66875 pence per share as of 10 June 2024. Following this redemption, the Company has 266,016,390 ordinary shares in issue.

No new investment activity is planned for the current quarter. The focus remains on the orderly realisation of the portfolio and the active management of the portfolio by the Investment Manager, aiming to accelerate redemptions or disposals where possible, in line with the Investment Manager's published realisation plan (the "Realisation Plan").

Portfolio update

In determining the 30 June 2024 valuations, Mazars, the Company's independent valuation agent, has applied certain asset-specific discount rate adjustments or impairments to reflect updates to loan and/or borrower performance during the period. During the period, £87.7 million in repayments were received, reducing the number of total loans outstanding from 39 to 31. As announced by the Company on the 8 July 2024, an additional repayment of £10.1m was received after the 30 June 2024, reducing total outstanding facilities to £244.4 million. Additionally, £7.8 million of interest was realised over the period.

Two assets were removed from the Watchlist or Problem Loans list during the quarter, with six loans classified as either Problem or Watchlist loans as of quarter-end. The Company and Investment Manager continue to work to resolve the remaining Problem and Watchlist loans. More details on the status of these loans is provided below:

Watchlist and Problem Loans (representing 11.6% of the 30 June 2024 NAV):

· Co-living group (0.0% NAV): This asset has been written down to nil (0.32% of the NAV at 31 March 2024) due to increased uncertainty on eventual recovery. Though recovery is still possible, the Investment Manager and Mazars believe the degree of uncertainty and limited control over the recovery process warrant a full impairment of the remaining facility. This is also in line with the recovery estimates set out in the Realisation Plan.

· Social housing (4.3% NAV): Classified as a Problem Loan due to persistent covenant breaches and failure to meet repayment obligations related to wider financial and regulatory challenges at one of the registered providers. The Investment Manager is progressing the early realisation of this investment in accordance with the Realisation Plan.

· Multi-use community facilities (0.3% NAV): The Investment Manager is in discussions to exit the position and is actively exploring a number of options.

· Student accommodation (0.5% NAV): The borrower has requested an extension to facilitate the refinancing or sale of the asset to repay the loan. Following the end of the reporting period, a positive planning decision was received regarding the property, which is expected to significantly increase the collateral value. This position will be reassessed in the second half of the year. The Investment Manager continues to work with the borrower to achieve an exit through sale, refinance, or redemption.

· Multi-use community facilities (0.9% NAV): Continued performance improvements have been seen, and the asset continues to make payments linked to turnover, in line with contractual requirements. The borrower has provided an updated long-term budget for the project during the period resulting in a further impairment of the facility. The position will continue to be monitored and the loan remains on the Watchlist until further improvement is established.

· Co-living (5.6% NAV): As previously communicated in the Company's 2023 annual report and accounts, this facility has been classified as a Watchlist loan due to the receipt by the Investment Manager of an updated valuation showing a breach of the facility's LTV covenant, and the borrower's failure to meet cash interest payments after the facility fell outside its contractual interest capitalisation period. The Investment Manager continues to engage with the borrower, who has made significant progress in stabilising the asset, noting consistently high occupancy levels and a key commercial tenant expected to take residence. This is expected to positively affect valuation and improve the LTV position. Discussions on a redemption of the facility are ongoing.

Further details will be provided in the Company's forthcoming interim accounts.

Dividends

On 25 April 2024, the Directors declared a quarterly dividend for the period from 1 January 2024 to 31 March 2024 of 1.58125p per share, which was paid on 4 June 2024. Aggregate dividend payments over the last 12 months represent a 8.3% yield on the Company's closing share price at 18 July 2024.

For further information:

GCP Asset Backed Income Fund Limited

Alex Ohlsson, Chairman

+44 (0)15 3482 2251

Gravis Capital Management Limited - Investment Manager

Philip Kent

Anthony Curl

Cameron Gardner

+44 (0)20 3405 8500

Barclays Bank PLC, acting through its Investment Bank - Corporate Broker

Dion Di Miceli

Stuart Muress

James Atkinson

 

+44 (0) 20 7623 2323

BarclaysInvestmentCompanies@barclays.com

Buchanan/Quill - Media Enquiries

Helen Tarbet

Henry Wilson

George Beale

 

+44 (0)20 7466 5000

Notes to the Editor

About GABI

GCP Asset Backed Income Fund Limited is a closed ended investment company. Its shares are traded on the Premium Segment of the Main Market of the London Stock Exchange. Its investment objective is to undertake a managed wind-down of the Company and realise all existing assets in the Company's portfolio in an orderly manner.

The Company's portfolio comprises a diversified portfolio of predominantly UK based asset backed loans which are secured against contracted, predictable medium to long term cash flows and/or physical assets.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PFUGCGDRUDDDGSU
Date   Source Headline
14th Aug 20177:00 amRNSNew social infrastructure investment
10th Aug 20177:00 amRNSScrip Share Reference Price
7th Aug 201711:38 amRNSHolding(s) in Company
2nd Aug 201711:58 amRNSInvestor Report 30 June 2017
1st Aug 201711:18 amRNSTotal Voting Rights & Additional Listing
28th Jul 20177:00 amRNSConversion of C shares
27th Jul 20177:00 amRNSDividend Declaration & Scrip Dividend Alternative
18th Jul 20177:00 amRNSNet Asset Value(s)
18th Jul 20177:00 amRNSConversion of C Shares
27th Jun 20171:37 pmRNSNew Investments
9th Jun 20179:47 amRNSNew Investment
2nd Jun 20172:54 pmRNSNew investment
30th May 201711:31 amRNSNew investment
23rd May 201712:28 pmRNSResult of AGM
2nd May 20179:25 amRNSInvestor Report as at 31 March 2017
25th Apr 20171:06 pmRNSDividend Declaration
24th Apr 20174:25 pmRNSAnnual General Meeting
20th Apr 20179:32 amRNSNovation of investment management agreement
19th Apr 20177:00 amRNSNet Asset Value(s)
13th Apr 20177:00 amRNSAnnual Report & Financial Statements
7th Apr 201712:36 pmRNSNew Directorship Notification
24th Mar 20177:00 amRNSInvestment commitment of £7 million
10th Mar 20172:55 pmRNSInvestment commitment of £17.5 million
2nd Mar 20172:26 pmRNSHolding(s) in Company
1st Mar 201710:37 amRNSTotal Voting Rights
15th Feb 20174:46 pmRNSHolding(s) in Company
10th Feb 201711:46 amRNSResult of OO, Placing & OFS
8th Feb 20173:39 pmRNSCorrection to Prospectus
25th Jan 20174:46 pmRNSInvestor Report as at 31 December 2016
25th Jan 20179:44 amRNSNon-Mainstream Pooled Investments
20th Jan 20174:05 pmRNSC Share Issue and Publication of Prospectus
18th Jan 20173:55 pmRNSDividend Declaration
13th Jan 20173:22 pmRNSNet Asset Value(s)
13th Jan 20171:39 pmRNSRevolving Credit Facility and further investment
5th Jan 20171:48 pmRNSProposed C Share Issue
23rd Dec 201612:48 pmRNSSocial infrastructure investments of £13.5 million
16th Dec 201611:27 amRNSInvestment commitment of £15.0 million
13th Dec 20163:48 pmRNSHolding(s) in Company
1st Dec 20167:00 amRNSTotal Voting Rights
21st Nov 201611:18 amRNSHolding(s) in Company
11th Nov 20163:14 pmRNSHolding(s) in Company
9th Nov 20163:04 pmRNSHolding(s) in Company
8th Nov 20167:00 amRNSResult of Placing
2nd Nov 20167:00 amRNSPlacing of New Ordinary Shares
25th Oct 201612:41 pmRNSInvestor Report as at 30 September 2016
20th Oct 20164:19 pmRNSHolding(s) in Company
19th Oct 20161:05 pmRNSReplacement Dividend Declaration
19th Oct 201612:56 pmRNSProposed Equity Raise
19th Oct 201612:51 pmRNSDividend Declaration
18th Oct 20168:00 amRNSTotal Voting Rights & Additional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.